Research

Cellular

The incidence of gastrointestinal adverse effects with tirzepatide was similar to that of semaglutide.

Tirzepatide may have a similar safety profile regarding gastrointestinal effects compared to semaglutide.

StrongSupportsmedium confidence
Incidence of gastrointestinal adverse effects (AE) was similar to semaglutide.
Courtney L. Bradley et al. · Annals of Pharmacotherapy · 2022

Why this rating

Based on the results of seven phase 3 randomized trials.

Source

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice

Courtney L. Bradley et al. · Annals of Pharmacotherapy · 2022

DOI 10.1177/10600280221134127

reviewCited 13×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →